Subscribe

Grants & Funding

Alzheimer's Drug Discovery Foundation

Published Date: January 13, 2010

Program Information

Program Name:
ADDF Biotechnology Development Program
Program URL:
http://www.alzdiscovery.org/wp-content/uploads/2009/08/2009-addf-general-rfp1.pdf
Type of Scientists Funded:
Advanced PhD Postdoc, Junior Faculty, Senior Scientist/Faculty
Program Description:
The Alzheimer's Drug Discovery Foundation (ADDF) funds drug discovery research programs from domestic and international investigators in academia and biotechnology companies. In addition, ADDF initiates, sponsors, and co-sponsors conferences to stimulate new ideas and approaches in areas of interest to the foundation, bringing together physicians, scientists, and policy makers worldwide.

The ADDF Biotechnology Development Program supports qualified scientific projects in existing, private, early-stage biotechnology companies. ADDF will provide support for qualified projects in more advanced companies if a clear need for nonprofit funding to support the project can be demonstrated and justified.

ADDF supports the development of biomarkers, such as (1) advanced brain imaging technologies, (2) cerebral spinal fluid tests and (3) blood tests for the early detection of mild cognitive impairment, Alzheimer's disease and related dementias. ADDF also supports clinical research projects to improve early detection of cognitive impairment through population-based approaches that can impact large numbers of individuals at risk.

Grant applications are usually solicited by private invitation. Unsolicited proposals are also accepted, but inquiries with ADDF staff are encouraged to determine the foundation's interest prior to application. ADDF provides support for 1 year of research with potential for future follow-on funding. The foundation seeks successful long-term partnerships with investigators and research organizations.

Public Contact Information

Name: Diana Shineman Ph.D.
Title: Assistant Director for Scientific Affairs
Organization: Alzheimer's Drug Discovery Foundation
Department:
Address: 1414 Avenue of the Americas
Suite 1502
New York, New York 10019
Phone: 212-901-8003
Fax:
E-mail: dshineman@alzdiscovery.org
Country: United States

Program Award Term and Application Process

  • Award Term Fixed or Variable?    Fixed
  • If fixed, enter total term?    1  Year
  • Award Renewable?    Yes
  • Renewable term fixed or variable?    Fixed
  • If fixed, enter total term?    1  Year
  • Does an individual or institution apply to the program?    Individual
  • Is there an application deadline?    Yes
  • Application deadline(s):
    04/01/2010,
    07/01/2010,
    10/01/2010
  • Deadline Comments   
    Grant applications are reviewed quarterly and are usually solicited by private invitation. Unsolicited proposals are also accepted, but inquiries with ADDF staff are encouraged to determine the Foundation's interest prior to application. ADDF provides support for 1 year of research with potential for future follow-on funding. We seek successful long-term partnerships with investigators and research organizations.

    Full application guidelines and further information can be found on our website. All applicants are required to complete an electronic "Letter of Intent" (LOI) available on our website. LOI should be submitted at least 2 weeks before the application deadline. After review of the LOI, we may invite a full application via email with a link to the electronic application form. ADDF will attempt to make a determination of interest within 90 days of receipt of the application.

Program FUNDS

  • Stipend Information:

  • Annual stipend type:    Percentage
  • Percent:    0-100 %

  • Research Allowance Information:


  • Annual research allowance type:    Variable
  • Minimum:    $ 0
  • Maximum:    $ 300000

  • Indirect Costs (Institutional Funds) Information:


  • Indirect costs type:    Not Applicable

  • Other Costs Information:


  • Other Costs type:    Not Applicable

Program Eligibility Requirements

Research Areas:
Biochemistry, Biology, Cell Biology, Clinical Research, Disease-Specific Research: Alzheimer's Disease, Molecular Biology, Neuroscience, Pharmacology, Other (specify): Biotechnology
Application by invitation or nomination only?
No
Are awards limited to specific groups?
None provided
Must applicants be U.S. citizens and/or permanent residents?
No
U.S. geographic limits?
No
International geographic limits?
Institutional limits?
No
Non-research activity allowed for postdoctoral and junior faculty awards?
If yes, specify at least one of the following: percentage time and activities allowed

Program competition information

  • Number of Applicants in Most Recent Competition Year:    200
  • Number of Awards in Most Recent Competition Year:    30
  • Institutional Award Rates   
    Category # Applicants # Awards
    Institutional Awards    
  • Awardee's subsequent careers/accomplishments tracked after end of term?   
  • Total dollars awarded in the most recent competition year    3800000